英文别名:
testosterone isocaproate--dea*schedule iii item;Testosterone isocaproate;Testosterone 17-Isocaproate;TESTOSTERONE ISOCAPROATE, BP2002;Testosteroneisocapronate;[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 4-methylpentanoate;17beta-Hydroxyandrost-4-ene-3-one 4-methylvalerate;4-Androsten-17b-ol-3-one 17-[4-Methylpentanoate];(8R,9S,10R,13S,14S,17S);Testosterone 17-isohexanoate;TESTOSTERONE 4-METHYLVALERATE;TESTOSTERONE4-METHYLPENTANOATE;Testosterone Isocaproate (CIII);Testosterone Isocaproate(Testostero);4-Androsten-17β-ol-3-one Isocapronate;TESTOSTERONE ISOCAPRONATE;Testosterone isocaproate(15262-86-9);Androst-4-en-3-one, 17-[(4-methyl-1-oxopentyl)oxy]-, (17b)-;3-OXOANDROST-4-EN-17.BETA.-YL 4-METHYLPENTANOATE;GTPL7629;Testosterone isocaproate, European Pharmacopoeia (EP) Reference Standard;Testosterone, 17-(4-methylvalerate);A809335;PPYHLSBUTAPNGT-BKWLFHPQSA-N;BDBM50103618;[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxidanylidene-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 4-methylpentanoate;Testosterone isocaproate for system suitability;NS00015427;D97820;Androst-4-en-3-one, 17-[(4-methyl-1-oxopentyl)oxy]-, (17.beta.)-;Testosterone, 17-(4-methylpentanoate);UNII-X8ST05GYDM;NSC-26641;NSC26641;EINECS 239-307-1;TESTOSTERONE ISOCAPROATE [WHO-DD];SCHEMBL354423;Testosterone isocaproate, analytical standard;CHEMBL3189011;DTXSID0046806;W-108049;TESTOSTERONE ISOCAPROATE [EP MONOGRAPH];X8ST05GYDM;Tox21_112669;AKOS015901952;TESTOSTERONE ISOCAPROATE [MART.];Androst-4-en-3-one, 17-((4-methyl-1-oxopentyl)oxy)-, (17beta)-;Testosterone 17-Isocaproate (1.0 mg/mL in Acetonitrile);(8R,9S,10R,13S,14S,17S)-10,13-Dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl 4-methylpentanoate;Testosterone Isocaproate 1.0 mg/ml in Acetonitrile;17.BETA.-HYDROXYANDROST-4-EN-3-ONE 4-METHYLPENTANOATE;4-methylpentanoic acid [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] ester;DTXCID8026806;NCGC00181019-01;15262-86-9;Q21099574;DS-11482;CHEBI:35001;Androst-4-en-3-one, 17-(4-methyl-1-oxopentyloxy]-;(1S,3aS,3bR,9aR,9bS,11aS)-9a,11a-dimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl 4-methylpentanoate;CAS-15262-86-9;2-(1-IMIDAZOYLSULFONYL)-1,3,5-TRI-O-BENZOYL-ALPHA-D-RIBOFURANOSE;NSC 26641;Testosterone isocaproate for system suitability, European Pharmacopoeia (EP) Reference Standard;Testosterone, 17-isocaproate;TESTOSTERONE ISOCAPROATE (MART.);((8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta(a)phenanthren-17-yl) 4-methylpentanoate;3-OXOANDROST-4-EN-17BETA-YL 4-METHYLPENTANOATE;17BETA-HYDROXYANDROST-4-EN-3-ONE 4-METHYLPENTANOATE;TESTOSTERONE ISOCAPROATE (EP MONOGRAPH);